April 10, 2018
Gasworld spoke to Jerry Shelton, Cryoport’s CEO, to find out how the latest regenerative medicines wouldn’t be possible without an often overlooked, yet extremely important component: logistics.s. Read Full Interview >
Tags: Clinical Trials Logistics, Temperature Controlled Logistics, Frozen Biological Shipping
©2023 Cryoport Systems, LLC. All rights reserved.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC